{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:24Z","timestamp":1791478044521,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.clinthera.2013.08.012","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T14:01:36Z","timestamp":1379340096000},"page":"1528-1535","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacokinetic Interactions Between Eperisone Hydrochloride and Aceclofenac: A Randomized, Open-Label, Crossover Study of Healthy Korean Men"],"prefix":"10.1016","volume":"35","author":[{"given":"Mi Jo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Seok","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yook-Hwan","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Youn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Mi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyun-Seop","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.08.012_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/03007999509110491","article-title":"A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis","volume":"13","author":"Pasero","year":"1995","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2013.08.012_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00003495-199652010-00008","article-title":"Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management","volume":"52","author":"Brogden","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2013.08.012_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.joca.2007.02.008","article-title":"Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial","volume":"15","author":"Batlle-Gualda","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2013.08.012_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14656566.5.6.1347","article-title":"Aceclofenac in the management of inflammatory pain","volume":"5","author":"Legrand","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2013.08.012_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1185\/03007995.2013.795139","article-title":"Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis","volume":"29","author":"Pareek","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2013.08.012_bib6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2165\/00003495-200161090-00012","article-title":"Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease","volume":"61","author":"Dooley","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2013.08.012_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.clinthera.2008.04.008","article-title":"Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers","volume":"30","author":"Rhim","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2013.08.012_bib8","doi-asserted-by":"crossref","unstructured":"Sakai Y, Matsuyama Y, Nakamura H, et al. The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain. Spine (Phila Pa 1976). 2008;33:581\u2013587.","DOI":"10.1097\/BRS.0b013e318166e051"},{"key":"10.1016\/j.clinthera.2013.08.012_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13318-011-0034-0","article-title":"Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry","volume":"36","author":"Melilli","year":"2011","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.08.012_bib10","unstructured":"Eisai Co. myonal drug information. 2012. http:\/\/www.eisai.jp\/medical\/products\/di\/EPI\/MYO_T-G_EPI.pdf. Accessed June 24, 2013."},{"key":"10.1016\/j.clinthera.2013.08.012_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3565(25)24210-0","article-title":"Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery","volume":"235","author":"Fujioka","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2013.08.012_bib12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12325-008-0108-9","article-title":"Open experience with a new myorelaxant agent for low back pain","volume":"25","author":"Sartini","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2013.08.012_bib13","first-page":"373","article-title":"Ethical principles for medical research involving human subjects","volume":"79","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.clinthera.2013.08.012_bib14","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/BF02980255","article-title":"Determination of eperisone in human plasma by liquid chromatography-ESI-tandem mass spectrometry","volume":"30","author":"Jeoung","year":"2007","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.clinthera.2013.08.012_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/chromsci\/42.5.254","article-title":"Rapid and sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the determination of eperisone in human plasma: method and clinical applications","volume":"42","author":"Ding","year":"2004","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.clinthera.2013.08.012_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jpba.2007.11.009","article-title":"Simultaneous determination of aceclofenac and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry","volume":"46","author":"Kang","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.clinthera.2013.08.012_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2133\/dmpk.23.87","article-title":"Intestinal first-pass metabolism of CYP3A4 substrates","volume":"23","author":"Kato","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.08.012_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0009-9236(96)90208-8","article-title":"Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies","volume":"60","author":"Hellriegel","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.08.012_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0090-9556(25)07441-0","article-title":"Metabolism of aceclofenac in humans","volume":"24","author":"Bort","year":"1996","journal-title":"Drug Metab Dispos"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813008928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813008928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:41:45Z","timestamp":1746024105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813008928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0149291813008928"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.08.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}